NEW YORK – Takara Bio USA announced Monday it has collaborated with BioSyntagma and their partners to develop and validate a high-throughput SARS-CoV-2 detection method.
NEW YORK – Takara Bio USA announced Monday it has collaborated with BioSyntagma and their partners to develop and validate a high-throughput SARS-CoV-2 detection method.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.